EN | TR
E-ISSN: 3061-9947
Clinicopathological Features of Young Gastric Cancer and New Inflammatory Prognostic Markers
PDF
Cite
Share
Request
Original Article
VOLUME: 56 ISSUE: 2
P: 90-96
2023

Clinicopathological Features of Young Gastric Cancer and New Inflammatory Prognostic Markers

Acta Haematol Oncol Turc 2023;56(2):90-96
DOI: 10.5505/aot.2023.74317
Ahmet Gülmez 1
Mustafa Dikilitaş 2
1. Adana City Education and Research Hospital
2. Inonu University Medicine High School; Medical Oncology Department Malatya
3.
No information available.
No information available
Received Date: 2022-08-05T19:14:51
Accepted Date: 2023-08-07T09:01:18
PDF
Cite
Share
Request

Abstract

INTRODUCTION

This study aimed to evaluate the clinicopathologic features of young gastric cancer (GC) patients and to investigate the factors affecting survival (OS).

METHODS

In this study, the data of 55 patients diagnosed under the age of 40 were obtained by retrospective evaluation of hospital records. Clinicopathological features and some laboratory parameters of this patient group and new inflammatory prognostic markers (IPM) obtained from these parameters were evaluated.

RESULTS

The mean age of the patients in this study was 33 years. The majority of the patients were male. Patients were evaluated according to human C-erbB2 positivity too. The identified patients as positive were only 7% of all patients. Also, the patients were evaluated for platinum sensitivity too. It was found that 30% of the patients were sensitive to platinum treatments. Also, survival times of the patients were evaluated with IPM. Neutrophil-lymphocyte ratio (NLR), mean platelet volume/platelet count, C-reactive protein/albumin ratios were calculated separately. Survival results were analyzed based on the mean values of all 3 prognostic markers. Even though there was a significant numerical difference, no statistical significance was found.

DISCUSSION AND CONCLUSION

This study was conducted to examine the clinicopathological features and survival time of young GC patients. Low C-erbB2 positivity and high platinum resistance were found among this patient population. In addition, inflammatory prognostic markers, which were found to be associated with survival in most cancers, were found to cause significant numerical differences in terms of survival in our study.